drug

LXE408

1 story · latest Sep 11, 2026

Status: Investigational
Trials: 2 registered trials in coverage

Relationships

Developed by Novartis

Timeline

Novartis registers Phase 3 urticaria, pruritus trials; posts malaria and leishmaniasis data

Sep 11Weekly roundup, 5 itemscipargamin INE963

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.